Meeting
2021 ASCO Annual Meeting
Real-world first-line (1L) treatment patterns in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) in a U.S. health insurance database.
Authors
Umang Swami
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
Umang Swami , Agnes Hong , Nader N. El-Chaar , David Nimke , Krishnan Ramaswamy , Elizabeth J. Bell , Rickard Sandin , Neeraj Agarwal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Prostate Cancer– Advanced/Hormone-Sensitive
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 5072)
DOI
10.1200/JCO.2021.39.15_suppl.5072
Abstract #
5072
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Real-world treatment patterns among patients diagnosed with metastatic castration-sensitive prostate cancer (mCSPC) in community oncology settings.
First Author: Daniel J. George
Poster
2021 ASCO Annual Meeting
Real-world utilization of advanced therapies and racial disparity among patients with metastatic castration-sensitive prostate cancer (mCSPC): A Medicare database analysis.
First Author: Stephen J. Freedland
Poster
2022 ASCO Genitourinary Cancers Symposium
Evolving real-world patterns of practice in metastatic castration-sensitive prostate cancer (mCSPC): The genitourinary research consortium (GURC) national multicenter cohort study.
First Author: Steven Yip
Poster
2022 ASCO Genitourinary Cancers Symposium
Practice patterns in the management of metastatic castration-sensitive prostate cancer: A single-center survey-based study.
First Author: Eric Lu